What psychiatric medication actually does — and what it doesn't

You come out of an appointment holding a prescription and a leaflet. The leaflet is four thousand words long, written by a legal department, and lists everything anyone has ever reported while taking the drug. Somewhere in there is the information you actually needed. Somewhere in the appointment was the sentence that would have made sense of it, and there wasn't time.

This is that sentence, unpacked.

The chemical imbalance story, and why it got quietly retired

For about thirty years people were told, in clinics and in adverts, that depression was low serotonin and the tablet topped it up. It was a tidy story. It was easy to say in ninety seconds. It is not what the evidence supports, and most clinicians stopped saying it some years ago.

A lot of people find that news destabilising, and I understand why — it sounds like being told the medication was a con. It isn't that. Two things can both be true: the simple explanation was wrong, and the medication does something measurable. Aspirin worked for the best part of a century before anyone could say why. Not knowing the mechanism precisely is a gap in the science, not proof the drug is inert.

What is honest to say is this: we know a good deal about what these drugs do to receptors and neurotransmitters, and much less about why that translates into someone being able to get out of bed in March when they couldn't in January.

The timing clue everyone skips past

Here is the detail that tells you the "top-up" model was never right. An SSRI changes the amount of serotonin available in the synapse within hours of the first dose. But the mood benefit, if it comes, takes weeks — the NHS puts it at one to two weeks before you notice anything and up to eight weeks for the full effect.

If it were a simple top-up, you'd feel better on day two. You don't. Which means the neurotransmitter change is the start of a chain, not the effect itself. The current thinking is that the brain adapts to that changed signal over weeks — receptors change sensitivity, and there's decent evidence of changes in how readily the brain forms new connections. The tablet opens a door. The weeks that follow are you walking through it.

This is not a technicality. It is the single most practically important fact about antidepressants, because it explains why stopping on day ten — when you feel queasy and no happier — is the most common way a medication that would have worked never gets the chance. There's a whole post on that: what the first six weeks actually feel like.

What medication can realistically do

Set against what people hope for, the real list is narrower and more useful:

• Lower the intensity. The thought still arrives; it doesn't arrive with the same force, and it doesn't stay as long.
• Raise the floor. Bad days stop bottoming out quite so far. For a lot of people this matters more than good days getting better.
• Give you back the capacity to do the other work. Therapy asks you to notice a thought, challenge it, tolerate discomfort and practise something new. That takes working memory, sleep and a bit of energy. If you have none of those, therapy isn't failing you — you can't get to it yet.
• Prevent the next episode. For some conditions the strongest evidence isn't about getting well at all. It's about staying well, which is quieter and less dramatic and matters enormously.
• Buy time. Sometimes the job is simply to keep someone alive and functioning until the circumstances change or the therapy lands.

What it cannot do

Medication does not fix a job that is grinding you down, a bereavement, a damp flat, debt, a controlling partner, racism at work, or being profoundly lonely. It will make some of those more survivable. It will not make them stop.

This matters because when the tablet doesn't fix the unfixable thing, people conclude the medication has failed, and stop. Sometimes the honest read is that the medication is doing its part and the rest of the plan — housing, money, therapy, a different job, people — hasn't been built yet.

It also does not turn you into someone else. The fear of being "not me any more" is near-universal and worth saying out loud in the appointment. Emotional blunting is real and is discussed later in this series; it is a side effect to report, not the price of entry.

The bar for "it's working"

Nobody sets this in advance and it causes endless confusion. "Working" almost never means no symptoms. A reasonable target looks more like:

• Sleeping, and the sleep restoring something.
• Eating roughly like a person again.
• The worst hour of the day being shorter.
• Being able to do one thing you'd been unable to do — answer the phone, leave the house, go to work.
• People who know you saying you seem more like yourself, even if you don't feel it yet.

Notice that most of those are things you'd only spot by looking back. That's why keeping a two-line note on your phone through the first two months is worth more than any amount of introspection at week three.

The classes, in one line each

A rough map. Each of these gets its own post later in the series.

• Antidepressants — used in depression and, very commonly, in anxiety disorders, OCD and PTSD. The name undersells the range.
• Antipsychotics — used in psychosis and schizophrenia, but also in bipolar disorder and sometimes alongside an antidepressant. A badly-chosen name that frightens people unnecessarily.
• Mood stabilisers — lithium and certain anti-seizure medicines, mainly in bipolar disorder. Very different drugs sharing an umbrella term.
• Anxiolytics and hypnotics — benzodiazepines and sleeping tablets. Effective fast, prescribed briefly and deliberately, for good reasons.
• ADHD medication — stimulants and non-stimulants, with their own monitoring.